Skip to main content
Clinical Trials/NCT03399864
NCT03399864
Completed
Not Applicable

Effectiveness of Musical Training in Reducing Depressive Symptoms, Enhancing Self-esteem and Quality of Life Among Hong Kong Chinese Childhood Brain Tumor Survivors - A Pilot Randomized Controlled Trial

The University of Hong Kong1 site in 1 country60 target enrollmentFebruary 20, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Neoplasms
Sponsor
The University of Hong Kong
Enrollment
60
Locations
1
Primary Endpoint
Change in depressive symptoms from baseline at 12-month follow-up between intervention and control group.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study aims to work out the effectiveness (effect size) of the musical training intervention in reducing depressive symptoms, improving self-esteem and quality of life among childhood brain tumour survivors and to examine the feasibility, appropriateness, and acceptability of implementing musical training intervention in clinical practice. Subjects in the experimental group will receive weekly 45-minute lessons on musical training for one year (52 weeks), while those in the control group will receive usual care.

Detailed Description

Musical training has been increasingly implemented to promote one's psychological well-being and cognitive functioning. For instance, to reduce depression, anxiety in psychiatric patients, to improve self-esteem and mood recognition in hospitalized adolescent patients diagnosed with "adjustment reaction to adolescence", to improve social skills of children with autism, to enhance reading skills and academic achievement in young poor readers, and to facilitate children's cognitive development. Nevertheless, the effectiveness of musical training in promoting psychological well-being, particularly to reduce their depressive symptoms and enhance self-esteem, and enhancing quality of life among the childhood brain tumour survivors is remain underexplored. It is of paramount importance to examine the effectiveness of musical training so as to ameliorate adverse disease- and treatment-related late effects, such as depression and low self-esteem, hence enhancing childhood brain tumour survivors' quality of life.

Registry
clinicaltrials.gov
Start Date
February 20, 2017
End Date
June 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hong Kong Chinese children surviving from brain tumours with the Modified Mini-Mental Scale (MMSE) score of 18 or above
  • be aged between 7 and 16 years
  • able to speak Cantonese and read Chinese
  • have completed treatment for at least two months
  • have residual function of the upper extremities (i.e. be able to move the extremities, such as the fingers and arms, without assistance)

Exclusion Criteria

  • children who have undertaken any musical training following their cancer diagnosis
  • survivors with evidence of recurrence or second malignancies
  • survivors receiving palliative care

Outcomes

Primary Outcomes

Change in depressive symptoms from baseline at 12-month follow-up between intervention and control group.

Time Frame: 12-month follow-up

The subjects' depressive symptoms will be assessed at 12-month after starting the intervention using the Chinese version of the Center for Epidemiological Studies Depression Scale for Children (CES-DC). The CES-DC is a commonly used tool in assessing the number of depressive symptoms of children and adolescent (Radloff, 1977). It consists of 20 items which are rated on a 4-point Likert scale from 0 to 3 (0= "not at all", 1 = "a little", 2 = "sometimes", 3= "a lot") regarding the subjects' feelings and experiences of last week. A possible scores ranging from 0 to 60 will be obtained after summing up all the items. Higher scores indicate greater number of depressive symptoms experienced. The cut-off score of this scale is 16, which indicates the children or the adolescents are currently experiencing a significant level of depressive symptoms.

Secondary Outcomes

  • Change in depressive symptoms from baseline at 6-month follow-up between intervention and control group(6-month follow-up)
  • Level of self-esteem at baseline between intervention and control group(baseline)
  • Depressive symptoms at baseline between intervention and control group(baseline)
  • Change in level of self-esteem from baseline at 6-month between intervention and control group(6-month follow-up)
  • Quality of life at baseline between intervention and control group(baseline)
  • Change in level of self-esteem from baseline at 12-month between intervention and control group(12-month follow-up)
  • Change in Quality of life at 12-month follow-up between intervention and control group(12-month follow-up)
  • Change in Quality of life at 6-month follow-up between intervention and control group(6-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials